164 related articles for article (PubMed ID: 17500103)
1. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007.
Wkly Epidemiol Rec; 2007 May; 82(19):164-7. PubMed ID: 17500103
[No Abstract] [Full Text] [Related]
2. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines.
Wkly Epidemiol Rec; 2006 Aug; 81(34/35):328-30. PubMed ID: 16933379
[No Abstract] [Full Text] [Related]
3. Antigenic and genetic characteristics of H5N1 viruses and candidate vaccine viruses developed for potential use in human vaccines, February 2009.
Wkly Epidemiol Rec; 2009 Feb; 84(9):72-6. PubMed ID: 19248289
[No Abstract] [Full Text] [Related]
4. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines - February 2010.
Wkly Epidemiol Rec; 2010 Mar; 85(11):100-7. PubMed ID: 20229648
[No Abstract] [Full Text] [Related]
5. Antigenic and genetic characteristics of influenza A(H5N1) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2009 Oct; 84(41):432-6. PubMed ID: 19817020
[No Abstract] [Full Text] [Related]
6. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
[No Abstract] [Full Text] [Related]
7. Vaccines for pandemic influenza.
Luke CJ; Subbarao K
Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
[TBL] [Abstract][Full Text] [Related]
8. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2011 Oct; 86(43):469-80. PubMed ID: 22046595
[No Abstract] [Full Text] [Related]
9. Strategies for developing vaccines against H5N1 influenza A viruses.
Horimoto T; Kawaoka Y
Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
[TBL] [Abstract][Full Text] [Related]
10. Antigenic and genetic characteristics of zoonotic influenza viruses and development of candidate vaccine viruses for pandemic preparedness.
Wkly Epidemiol Rec; 2014 Oct; 89(42):457-64. PubMed ID: 25337626
[No Abstract] [Full Text] [Related]
11. Reference viruses for seasonal and pandemic influenza vaccine preparation.
Wood JS; Robertson JS
Influenza Other Respir Viruses; 2007 Jan; 1(1):5-9. PubMed ID: 19459278
[TBL] [Abstract][Full Text] [Related]
12. Improving pandemic H5N1 influenza vaccines by combining different vaccine platforms.
Luke CJ; Subbarao K
Expert Rev Vaccines; 2014 Jul; 13(7):873-83. PubMed ID: 24855993
[TBL] [Abstract][Full Text] [Related]
13. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
14. Antigenic and genetic characteristics of influenza A(H5N1)and influenza A(H9N2) viruses and candidate vaccine viruses developed for potential use in human vaccines.
Wkly Epidemiol Rec; 2010 Oct; 85(42):418-24. PubMed ID: 20949701
[No Abstract] [Full Text] [Related]
15. H5N1 vaccine hits the target, but not the bull's eye.
Sambhara S; Bridges CB; Poland GA
Lancet Infect Dis; 2007 Aug; 7(8):503-5. PubMed ID: 17646023
[No Abstract] [Full Text] [Related]
16. Influenza A (H5N1) pandemic prototype vaccine Fluval.
Vajo Z
Expert Rev Vaccines; 2009 May; 8(5):619-24. PubMed ID: 19397418
[TBL] [Abstract][Full Text] [Related]
17. Development of live-attenuated influenza vaccines against outbreaks of H5N1 influenza.
Zheng D; Yi Y; Chen Z
Viruses; 2012 Dec; 4(12):3589-605. PubMed ID: 23223214
[TBL] [Abstract][Full Text] [Related]
18. Current status and progress of prepandemic and pandemic influenza vaccine development.
Leroux-Roels I; Leroux-Roels G
Expert Rev Vaccines; 2009 Apr; 8(4):401-23. PubMed ID: 19348557
[TBL] [Abstract][Full Text] [Related]
19. Vaccines for a potential influenza pandemic.
Auewarakul P; Thongcharoen P
Future Microbiol; 2007 Jun; 2(3):345-9. PubMed ID: 17661708
[TBL] [Abstract][Full Text] [Related]
20. Pandemic H5N1 influenza vaccine development: an update.
El Sahly HM; Keitel WA
Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]